bicalutamide and bilirubin

bicalutamide has been researched along with bilirubin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Glen, RC; Lowe, R; Mitchell, JB	1
Aguayo, J; Cole, A; Martin, E; Mathew, A; Mendelblatt, D; Vesely, DL	1

Other Studies

2 other study(ies) available for bicalutamide and bilirubin

Article	Year
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
Metastatic prostate cancer (with prostate-specific antigen of 9996) presenting as obstructive jaundice. The American journal of the medical sciences, 2000, Volume: 319, Issue:2 Topics: Aged; Alkaline Phosphatase; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bone Neoplasms; Cholestasis; Humans; Leuprolide; Lymphatic Metastasis; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome	2000

Article

Year

Predicting phospholipidosis using machine learning.

Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010

Metastatic prostate cancer (with prostate-specific antigen of 9996) presenting as obstructive jaundice.

The American journal of the medical sciences, 2000, Volume: 319, Issue:2

Topics: Aged; Alkaline Phosphatase; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bilirubin; Bone Neoplasms; Cholestasis; Humans; Leuprolide; Lymphatic Metastasis; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Tosyl Compounds; Treatment Outcome

2000